Trade Illumina Inc - ILMN CFD
Add to favourite- Summary
- Historical Data
Spread | 0.23 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 117.41 |
Open | 119.24 |
1-Year Change | -37.03% |
Day's Range | 119.24 - 122.96 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 116.88 | 1.63 | 1.41% | 115.25 | 121.47 | 115.24 |
Jul 24, 2024 | 116.21 | 1.45 | 1.26% | 114.76 | 118.36 | 113.63 |
Jul 23, 2024 | 115.46 | -2.64 | -2.24% | 118.10 | 118.58 | 115.16 |
Jul 22, 2024 | 117.52 | 2.56 | 2.23% | 114.96 | 117.99 | 113.91 |
Jul 19, 2024 | 114.30 | -1.04 | -0.90% | 115.34 | 115.97 | 113.21 |
Jul 18, 2024 | 115.23 | -4.05 | -3.40% | 119.28 | 121.28 | 115.23 |
Jul 17, 2024 | 119.80 | -4.16 | -3.36% | 123.96 | 125.68 | 119.27 |
Jul 16, 2024 | 125.18 | 8.47 | 7.26% | 116.71 | 125.53 | 116.48 |
Jul 15, 2024 | 116.43 | 1.24 | 1.08% | 115.19 | 117.47 | 114.21 |
Jul 12, 2024 | 115.94 | -2.31 | -1.95% | 118.25 | 119.38 | 115.32 |
Jul 11, 2024 | 117.89 | 2.67 | 2.32% | 115.22 | 119.27 | 114.14 |
Jul 10, 2024 | 112.68 | 1.49 | 1.34% | 111.19 | 113.64 | 107.61 |
Jul 9, 2024 | 106.60 | -0.45 | -0.42% | 107.05 | 107.64 | 104.46 |
Jul 8, 2024 | 107.77 | -0.93 | -0.86% | 108.70 | 109.95 | 107.44 |
Jul 5, 2024 | 108.40 | 3.36 | 3.20% | 105.04 | 108.97 | 104.43 |
Jul 3, 2024 | 104.91 | -0.04 | -0.04% | 104.95 | 106.56 | 103.95 |
Jul 2, 2024 | 105.42 | -0.03 | -0.03% | 105.45 | 107.40 | 105.42 |
Jul 1, 2024 | 105.16 | 1.05 | 1.01% | 104.11 | 108.09 | 103.47 |
Jun 28, 2024 | 103.88 | -2.81 | -2.63% | 106.69 | 106.72 | 103.31 |
Jun 27, 2024 | 106.36 | 1.43 | 1.36% | 104.93 | 107.14 | 104.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Illumina Company profile
What is Illumina?
Illumina Inc (ILMN) is a San Diego-based U.S. company engaged in the development and marketing of genetic analysis solutions and life science services. Over the past decade it has become a global leader in genomics. Illumina offers a broad portfolio of instruments including NovaSeq Sequencing Systems,HiSeq Sequencing Systems, HiScan Array Scanner and others.
Illumina explains that its aim is “to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago”. The company says it delivers innovative, flexible, and scalable solutions to meet the needs of its customers.These customers include leading genome research centres and a variety of other academic, governmental, pharmaceutical and biotechnology institutions around the world.
In 2017 Forbes ranked Illumina no.18 in its annual list of the world’s most innovative companies. The company was also ranked no.34 in its league table of America's best midsize employers, and no.175 in Forbes’ list of growth champions. As of 6 April 2018, Illumina Inc had a market capitalisation of some $34.14 billion.
Who are the key people at Illumina?
Francis de Souza, who has been President & CEO of Illumina Inc since 2016, is responsible for directing all aspects of company strategy, planning and operations. Other key figures at the company include: Garret Hampton (Executive Vice President, Clinical Genomics); Omead Ostadan (Executive Vice President, Products & Operations); and Marc Stapley (Executive Vice President, Strategy & Corporate Development).
What is the modern history of Illumina?
The company was foundedin 1998 by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock and Mark S. Chee. It acquired Spyder Instruments the following year, and completed its initial public offering in 2000. The acquisition of Solexa Inc followed in 2007, and Epicentre Biotechnologies was acquired in 2011. Roche made an unsolicited bid to buy Illumina for around $5.7 billion in 2012, but both this and a subsequent higher offer were rejected. In 2015, Illumina spun off the blood testing company Grail.
What are the latest developments at Illumina?
In its financial results for fiscal year 2017, Illumnia Inc reported revenue of $2.75 billion, a 15% increase from $2.40 billion in fiscal year 2016.GAAP net income attributable to Illumina stockholders was $726 million, or $4.92 per diluted share, against $463 million or $3.07 per diluted share in 2016.For fiscal year 2018, the company forecast 13-14% revenue growth, and GAAP earnings per diluted share attributable to Illumina stockholders of $4.14-$4.24.
Long-term investors in Illumina saw the value of their holdings increase significantly between 2013 and 2018. From $54 in January 2013, the Illumina share price climbed to $100 in December 2013, $150 in February 2014, and $200 in May 2015. The shares slipped in the second half of 2015, but by March 2018 the stock had recovered to a new high of $253. To find out how the shares are doing right now, follow Capital.com. Our ILMN chart puts all the information at your fingertips.
Where does Illumina operate?
Headquartered in San Diego, California,Illumina's regional subdivisions operate in the United States, Brazil, the United Kingdom, the Netherlands, Singapore, China, Japan and Australia.The company employs over 5,500 people.
Where is Illumina traded?
The company shares are traded on the NASDAQ stock exchange and are constituents of the S&P 500 index. Check out Capital.com for the latest ILMN chart. We’ll keep you up to date and in the picture.
Industry: | Advanced Medical Equipment & Technology (NEC) |
5200 Illumina Way
SAN DIEGO
CALIFORNIA 92122
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com